The trademark SUVOKRA was filed by DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD., a corporation established under the laws of the People's Republic of China (the "Applicant"). The application was published for oppositions on September 25, 2022, and received one opposition filed on December 8, 2022 by Novartis AG on Likelihood of confusion. the opponent was represented by Tresper, Thomas and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued December 8, 2022
The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).